A Prospective, Randomized, Controlled Clinical Investigation Comparing the Efficacy and Safety of Sodium Hyaluronate-Based Ophthalmical Viscosurgical Devices FIDIAL PLUS and IAL ® -F in Cataract Surgery
- 1 October 2024
- journal article
- research article
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 40 (8) , 469-476
Abstract
Purpose: To protect the corneal endothelium, various ophthalmical viscoelastic devices (OVDs) are used during cataract surgery. In this study, we compared two sodium hyaluronate-based OVD, the bacteria-derived FIDIAL PLUS OVD (test) with the animal-derived IAL ® -F OVD (reference) during the surgical procedure. Methods: Fifty patients with bilateral cataract participated in the study: 50 eyes randomly received FIDIAL PLUS and 50 eyes received IAL ® -F (ratio 1:1). Noninferior efficacy of FIDIAL PLUS compared with reference OVD (first objective) was evaluated using a paired t -test comparing the mean percent loss of corneal endothelial cells (CECs) with FIDIAL PLUS against the mean percent loss with IAL ® -F. Corneal endothelial protection during cataract surgery with FIDIAL PLUS without significant (≥30 mmHg) postoperative intraocular pressure (IOP) increase (main secondary objective) was assessed using a repeated measures logistic model comparing the incidence of significant postoperative IOP elevation between the two groups. Safety, tolerability, and efficacy were also evaluated by assessing secondary endpoints before and after surgery. Results: FIDIAL PLUS showed a statistically noninferior efficacy compared with IAL ® -F; there was no significant increase in IOP in either group or different trends of the secondary endpoints were observed between the OVD groups. The safety profile was similar in both OVD groups and no adverse device effects were reported. Conclusions: This study demonstrates the equivalent efficacy, tolerability, and safety of the bacteria-derived FIDIAL PLUS compared with the animal-derived IAL ® -F, confirming the clinical value of this product.Keywords
This publication has 29 references indexed in Scilit:
- Ophthalmic Viscosurgical Devices (OVDs) in Challenging Cases: a ReviewOphthalmology and Therapy, 2021
- Clinical evaluation of a bacterially derived sodium hyaluronate 2.3% ophthalmic viscosurgical deviceJournal of Cataract & Refractive Surgery, 2019
- Quantification of residual ophthalmic viscosurgical device after irrigation/aspiration in experimental cataract surgery in vitroJournal of Cataract & Refractive Surgery, 2019
- Preclinical Safety Evaluation of Ophthalmic Viscosurgical Devices in Rabbits and a Novel Mini-Pig ModelOphthalmology and Therapy, 2019
- Biotechnological production of hyaluronic acid: a mini review3 Biotech, 2016
- CataractsPrimary Care: Clinics in Office Practice, 2015
- Hyaluronic acid: a natural biopolymer with a broad range of biomedical and industrial applicationsBiotechnology Letters, 2006
- New classification of ophthalmic viscosurgical devices—2005Journal of Cataract & Refractive Surgery, 2005
- Safety and Efficacy of Phacoemulsification Compared with Manual Small-Incision Cataract Surgery by a Randomized Controlled Clinical TrialSix-Week ResultsOphthalmology, 2005
- Viscoelastic substances in ophthalmologySurvey of Ophthalmology, 1990